Advertisement

Network analysis characterizes key associations between subjective fatigue and specific depressive symptoms in early relapsing-remitting multiple sclerosis

Published:November 23, 2022DOI:https://doi.org/10.1016/j.msard.2022.104429

      Highlights

      • Fatigue severity in MS linked to a range of variables including depression
      • Overlap between fatigue and tiredness as depressive symptom complicates interpretation
      • Network analysis of large early RRMS cohort including structural MRI of brain
      • No link between fatigue severity and cognitive performance, or included MRI metrics
      • Fatigue linked to individual depressive symptoms in addition to tiredness

      ABSTRACT

      Background

      Fatigue is common and disabling in multiple sclerosis (MS), yet its mechanisms are poorly understood. In particular, overlap in measures of fatigue and depression complicates interpretation. We applied a multivariate network approach to quantify relationships between fatigue and other variables in early MS.

      Methods

      Data were collected from patients with newly diagnosed immunotherapy-naïve relapsing-remitting MS at baseline and month 12 follow-up in FutureMS, a Scottish nationally representative cohort. Subjective fatigue was assessed by Fatigue Severity Scale. Detailed phenotyping included measures assessing each of physical disability, affective disorders, cognitive performance, sleep quality, and structural brain imaging. Network analysis was conducted to estimate partial correlations between variables. Baseline networks were compared between those with persistent and remitted fatigue at one-year follow up.

      Results

      Data from 322 participants at baseline, and 323 at month 12, were included. At baseline, 154 patients (47.8%) reported clinically significant fatigue. In the network analysis, fatigue severity showed strongest connections with depression, followed by Expanded Disability Status Scale. Conversely, fatigue severity was not linked to objective cognitive performance or brain imaging variables. Even after controlling for measurement of “tiredness” in our measure of depression, four specific depressive symptoms remained linked to fatigue. Results were consistent at baseline and month 12. Overall network strength was not significantly different between groups with persistent and remitted fatigue (4.89 vs 2.90, p=0.11).

      Conclusions

      Our findings support robust links between subjective fatigue and depression in early relapsing-remitting MS. Shared mechanisms between specific depressive symptoms and fatigue could be key targets of treatment and research in MS-related fatigue.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Multiple Sclerosis and Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Global
        regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
        Lancet Neurol. 2019; 18: 459-480https://doi.org/10.1016/S1474-4422(18)30499-X
        • Kluger BM
        • Krupp LB
        • Enoka RM.
        Fatigue and fatigability in neurologic illnesses.
        Neurology. 2013; 80 (409 LP-416)https://doi.org/10.1212/WNL.0b013e31827f07be
        • Guidelines MSC for CP
        Fatigue and Multiple Sclerosis: Evidence-Based Management Strategies for Fatigue in Multiple Sclerosis: Clinical Practice Guidelines.
        The Council. 1998;
        • Heine M
        • van de Port I
        • Rietberg MB
        • van Wegen EEH
        • Kwakkel G.
        Exercise therapy for fatigue in multiple sclerosis.
        Cochrane database Syst Rev. 2015; CD009956https://doi.org/10.1002/14651858.CD009956.pub2
        • Alvarenga-Filho H
        • Salles M
        • Hygino J
        • et al.
        Fatigue favors in vitro Th1 and Th17-like cell expansion and reduces corticoid sensitivity in MS patients.
        J Neuroimmunol. 2017; 303: 81-89https://doi.org/10.1016/j.jneuroim.2016.12.013
        • Håkansson I
        • Johansson L
        • Dahle C
        • Vrethem M
        • Ernerudh J.
        Fatigue scores correlate with other self-assessment data, but not with clinical and biomarker parameters, in CIS and RRMS.
        Mult Scler Relat Disord. 2019; 36101424https://doi.org/10.1016/j.msard.2019.101424
        • Biberacher V
        • Schmidt P
        • Selter RC
        • et al.
        Fatigue in multiple sclerosis: Associations with clinical, MRI and CSF parameters.
        Mult Scler. 2018; 24: 1115-1125https://doi.org/10.1177/1352458517712078
        • Weiland TJ
        • Jelinek GA
        • Marck CH
        • et al.
        Clinically significant fatigue: prevalence and associated factors in an international sample of adults with multiple sclerosis recruited via the internet.
        PLoS One. 2015; 10e0115541https://doi.org/10.1371/journal.pone.0115541
        • Stanton BR
        • Barnes F
        • Silber E.
        Sleep and fatigue in multiple sclerosis.
        Mult Scler J. 2006; 12: 481-486https://doi.org/10.1191/135248506ms1320oa
        • Wilting J
        • Rolfsnes HO
        • Zimmermann H
        • et al.
        Structural correlates for fatigue in early relapsing remitting multiple sclerosis.
        Eur Radiol. 2016; 26: 515-523https://doi.org/10.1007/s00330-015-3857-2
        • Palotai M
        • Guttmann CR.
        Brain anatomical correlates of fatigue in multiple sclerosis.
        Mult Scler. 2020; 26: 751-764https://doi.org/10.1177/1352458519876032
        • Bakshi R
        • Shaikh ZA
        • Miletich RS
        • et al.
        Fatigue in multiple sclerosis and its relationship to depression and neurologic disability.
        Mult Scler. 2000; 6: 181-185https://doi.org/10.1177/135245850000600308
        • Feinstein A
        • Magalhaes S
        • Richard J-F
        • Audet B
        • Moore C.
        The link between multiple sclerosis and depression.
        Nat Rev Neurol. 2014; 10: 507-517https://doi.org/10.1038/nrneurol.2014.139
        • Gunzler DD
        • Perzynski A
        • Morris N
        • Bermel R
        • Lewis S
        • Miller D.
        Disentangling Multiple Sclerosis and depression: an adjusted depression screening score for patient-centered care.
        J Behav Med. 2015; 38: 237-250https://doi.org/10.1007/s10865-014-9574-5
        • Patrick S
        • Connick P.
        Psychometric properties of the PHQ-9 depression scale in people with multiple sclerosis: A systematic review.
        PLoS One. 2019; 14e0197943https://doi.org/10.1371/journal.pone.0197943
        • Ashaie SA
        • Hung J
        • Funkhouser CJ
        • Shankman SA
        • Cherney LR.
        Depression over time in persons with stroke: A network analysis approach.
        J Affect Disord Reports. 2021; 4100131https://doi.org/10.1016/j.jadr.2021.100131
        • van Borkulo C
        • Boschloo L
        • Borsboom D
        • Penninx BWJH
        • Waldorp LJ
        • Schoevers RA.
        Association of Symptom Network Structure With the Course of Depression.
        JAMA Psychiatry. 2015; 72: 1219-1226https://doi.org/10.1001/jamapsychiatry.2015.2079
        • Kearns PKA
        • Martin SJ
        • Chang J
        • et al.
        FutureMS cohort profile: a Scottish multicentre inception cohort study of relapsing-remitting multiple sclerosis.
        BMJ Open. 2022; 12e058506https://doi.org/10.1136/bmjopen-2021-058506
        • Meijboom R
        • Wiseman SJ
        • York EN
        • et al.
        Rationale and design of the brain magnetic resonance imaging protocol for FutureMS: a longitudinal multi-centre study of newly diagnosed patients with relapsing-remitting multiple sclerosis in Scotland.
        medRxiv. 2021; (January2021.03.10.21253264)https://doi.org/10.1101/2021.03.10.21253264
        • Krupp LB
        • LaRocca NG
        • Muir-Nash J
        • Steinberg AD.
        The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus.
        Arch Neurol. 1989; 46: 1121-1123https://doi.org/10.1001/archneur.1989.00520460115022
        • Kroenke K
        • Spitzer RL
        • Williams JB.
        The PHQ-9: validity of a brief depression severity measure.
        J Gen Intern Med. 2001; 16: 606-613https://doi.org/10.1046/j.1525-1497.2001.016009606.x
        • Beard C
        • Millner AJ
        • Forgeard MJC
        • et al.
        Network analysis of depression and anxiety symptom relationships in a psychiatric sample.
        Psychol Med. 2016; 46 (doi:DOI:): 3359-3369https://doi.org/10.1017/S0033291716002300
        • Association AP, Force APAD-5 T
        Diagnostic and Statistical Manual of Mental Disorders : DSM-5.
        (eds.) American Psychiatric Association, Arlington, VA2013
      1. R Core Team. R: A Language and Environment for Statistical Computing. 2020. https://www.r-project.org/.

        • Epskamp S
        • Fried EI.
        A tutorial on regularized partial correlation networks.
        Psychol Methods. 2018; 23: 617-634https://doi.org/10.1037/met0000167
        • Epskamp S
        • Borsboom D
        • Fried EI.
        Estimating psychological networks and their accuracy: A tutorial paper.
        Behav Res Methods. 2018; 50: 195-212https://doi.org/10.3758/s13428-017-0862-1
      2. van Borkulo, C. D., Waldorp, L. J., Boschloo, L., Kossakowski, J., Tio, P., L., Schoevers, R.A., & Borsboom D. Comparing network structures on three aspects: A permutation test. 2017. doi:10.13140/RG.2.2.29455.38569

        • Kearns PKA
        • Paton M
        • O'Neill M
        • et al.
        Regional variation in the incidence rate and sex ratio of multiple sclerosis in Scotland 2010-2017: findings from the Scottish Multiple Sclerosis Register.
        J Neurol. 2019; (June)https://doi.org/10.1007/s00415-019-09413-x
        • Schober P
        • Boer C
        • Schwarte LA.
        Correlation Coefficients: Appropriate Use and Interpretation.
        Anesth Analg. 2018; 126
        • Patejdl R
        • Penner IK
        • Noack TK
        • Zettl UK.
        Multiple sclerosis and fatigue: A review on the contribution of inflammation and immune-mediated neurodegeneration.
        Autoimmun Rev. 2016; 15: 210-220https://doi.org/10.1016/j.autrev.2015.11.005
        • Heitmann H
        • Andlauer TFM
        • Korn T
        • et al.
        Fatigue, depression, and pain in multiple sclerosis: How neuroinflammation translates into dysfunctional reward processing and anhedonic symptoms.
        Mult Scler. 2020; (November)1352458520972279https://doi.org/10.1177/1352458520972279
        • Gotlib IH
        • Joormann J.
        Cognition and depression: current status and future directions.
        Annu Rev Clin Psychol. 2010; 6: 285-312https://doi.org/10.1146/annurev.clinpsy.121208.131305
        • Manjaly Z-M
        • Harrison NA
        • Critchley HD
        • et al.
        Pathophysiological and cognitive mechanisms of fatigue in multiple sclerosis.
        J Neurol Neurosurg Psychiatry. 2019; 90: 642-651https://doi.org/10.1136/jnnp-2018-320050
        • Fried EI
        • Nesse RM.
        Depression sum-scores don't add up: why analyzing specific depression symptoms is essential.
        BMC Med. 2015; 13: 72https://doi.org/10.1186/s12916-015-0325-4
        • Janardhan V
        • Bakshi R.
        Quality of life in patients with multiple sclerosis: the impact of fatigue and depression.
        J Neurol Sci. 2002; 205: 51-58https://doi.org/10.1016/s0022-510x(02)00312-x
        • van Kessel K
        • Moss-Morris R.
        Understanding multiple sclerosis fatigue: a synthesis of biological and psychological factors.
        J Psychosom Res. 2006; 61: 583-585https://doi.org/10.1016/j.jpsychores.2006.03.006
        • Vaughn CB
        • Kavak KS
        • Dwyer MG
        • et al.
        Fatigue at enrollment predicts EDSS worsening in the New York State Multiple Sclerosis Consortium.
        Mult Scler. 2020; 26: 99-108https://doi.org/10.1177/1352458518816619
        • Pilutti LA
        • Greenlee TA
        • Motl RW
        • Nickrent MS
        • Petruzzello SJ.
        Effects of Exercise Training on Fatigue in Multiple Sclerosis: A Meta-Analysis.
        Psychosom Med. 2013; 75
        • Ehde DM
        • Elzea JL
        • Verrall AM
        • Gibbons LE
        • Smith AE
        • Amtmann D.
        Efficacy of a Telephone-Delivered Self-Management Intervention for Persons With Multiple Sclerosis: A Randomized Controlled Trial With a One-Year Follow-Up.
        Arch Phys Med Rehabil. 2015; 96 (e2): 1945-1958https://doi.org/10.1016/j.apmr.2015.07.015
        • Knowles LM
        • Arewasikporn A
        • Kratz AL
        • Turner AP
        • Alschuler KN
        • Ehde DM.
        Early Treatment Improvements in Depression Are Associated With Overall Improvements in Fatigue Impact and Pain Interference in Adults With Multiple Sclerosis.
        Ann Behav Med. 2020; (November)https://doi.org/10.1093/abm/kaaa102